Last reviewed · How we verify
NCT03607448
Freestyle Libre Flash Glucose Monitoring System
trial testing Freestyle Libre Flash Glucose Monitoring System in Diabetes Mellitus in 153 participants. Completed in 21 November 2018.
21 November 2018
Quick facts
| Lead sponsor | Abbott Diabetes Care |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 153 |
| Start date | 23 July 2018 |
| Primary completion | 21 November 2018 |
| Estimated completion | 21 November 2018 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- Freestyle Libre Flash Glucose Monitoring System
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Abbott Diabetes Care — full company profile →
Who can join
18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to characterize the Freestyle Libre Flash Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes.
Alva S, Bailey T, Brazg R, Budiman ES, et al · · 2022 · cited 103× · PMID 32954812 · DOI 10.1177/1932296820958754
Verify or expand the search:
- PubMed search for NCT03607448
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Abbott Diabetes Care trials
Trials by the same sponsor.
- NCT06268808 — Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy · NA · completed
- NCT06268821 — Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland · NA · terminated
- NCT05944432 — CGM Use in Adults With Type 2 Diabetes on Basal Insulin · NA · active not recruiting
- NCT05962710 — FreeStyle Libre 3 Continuous Glucose Monitoring System · terminated
- NCT05189938 — HbA1c Variation Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03607448 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abbott Diabetes Care
- Last refreshed: 29 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03607448.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing